EP
ANGO icon

Essential Partners’s AngioDynamics ANGO Stock Holding History

Essential Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.17K Hold
141
– – ﹤0.01% 1894
2026
Q2 		$1.83K Buy
141
+115
+442% +$1.31K ﹤0.01% 2006
2026
Q1 		$296 Sell
26
-3
-10% -$33 ﹤0.01% 2554
2025
Q4 		$372 Buy
29
+15
+107% +$185 ﹤0.01% 2298
2025
Q3 		$156 Buy
14
+1
+8% +$10 ﹤0.01% 2434
2025
Q2 		$129 Buy
+13
New +$127 ﹤0.01% 2033

Other funds holding ANGO

Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Essential Partners's ANGO Position: Q3 2026 in Review

Essential Partners held its AngioDynamics (ANGO) position steady in Q3 2026 at 141 shares worth $2.17K. The position accounts for ﹤0.01% of the portfolio, ranked #1894.

Essential Partners first reported a position in ANGO in Q2 2025 and has held it in 6 quarters since. 12 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

  • Essential Partners held 141 shares of AngioDynamics worth $2.17K as of Q3 2026.
  • Essential Partners left its AngioDynamics share count unchanged in Q3 2026.
  • AngioDynamics made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1894 holding.
  • Essential Partners first reported a position in AngioDynamics in Q2 2025 and has held it in 6 quarters since.
  • 12 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.